Annual Report 2021

2 The United Laboratories International Holdings Limited Annual Report 2021 CORPORATE CALENDAR OF 2021 • The United Laboratories’ Glipizide Tablets (specification: 5mg) passed the quality and efficacy consistency evaluation of generic drugs. • The United Laboratories’ Tenofovir Dipivoxil Fumarate Tablets (specification: 300mg) obtained the drug registration certificate and deemed to have passed the quality and efficacy consistency evaluation of generic drugs. • The United Laboratories (Inner Mongolia) successfully passed the authentication of Quality, Environmental, Occupational Health & Safety Management System. January • The United Laboratories won the first prize of Zhuhai Science and Technology Progress Award for 2020 for the project of Memantine Hydrochloride. • Zhongshan United Laboratories was admitted as “Hong Kong and Macao Youth Talent Internship Practice Base”. • Zhuhai United Laboratories Trading Company Limited was awarded as “Enterprise with Outstanding Contribution” and “Advanced Enterprise with Anti-epidemic Courage and Responsibility” in Zhuhai pharmaceutical industry for 2020 by the Zhuhai Pharmaceutical Circulation Industry Association. March • Zhuhai United Laboratories was qualified as “High-tech Enterprise of Guangdong Province for 2020”. • The project of “Research on the technology of New Mucus-penetrating Nanocrystal Eye Drops” declared by The United Laboratories was granted The Zhuhai Industry – University – Research Cooperation and Basic and Applied Basic Research Projects subsidies. • The Amoxicillin Capsule (specification: 0.25g) submitted by The United Laboratories, Limited (Hong Kong) passed the quality and efficacy consistency evaluation of generic drugs. April